JCRファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/05/20 | 7,280 | 7,350 | 7,050 | 7,110 | -150 | -2.1% | 110,000 |
2019/05/17 | 7,100 | 7,270 | 7,090 | 7,260 | +260 | +3.7% | 174,100 |
2019/05/16 | 6,950 | 7,050 | 6,940 | 7,000 | +30 | +0.4% | 108,100 |
2019/05/15 | 6,950 | 6,980 | 6,820 | 6,970 | +70 | +1% | 151,800 |
2019/05/14 | 6,730 | 7,090 | 6,620 | 6,900 | +120 | +1.8% | 269,900 |
2019/05/13 | 6,650 | 6,920 | 6,460 | 6,780 | +350 | +5.4% | 349,200 |
2019/05/10 | 6,410 | 6,560 | 6,340 | 6,430 | -40 | -0.6% | 100,400 |
2019/05/09 | 6,480 | 6,530 | 6,410 | 6,470 | +10 | +0.2% | 101,600 |
2019/05/08 | 6,420 | 6,500 | 6,390 | 6,460 | -90 | -1.4% | 94,900 |
2019/05/07 | 6,320 | 6,610 | 6,320 | 6,550 | +300 | +4.8% | 228,400 |
2019/04/26 | 6,200 | 6,260 | 6,130 | 6,250 | ±0 | ±0% | 86,100 |
2019/04/25 | 6,130 | 6,280 | 6,110 | 6,250 | +100 | +1.6% | 109,600 |
2019/04/24 | 6,160 | 6,220 | 6,100 | 6,150 | +50 | +0.8% | 63,100 |
2019/04/23 | 6,030 | 6,110 | 5,990 | 6,100 | +10 | +0.2% | 95,200 |
2019/04/22 | 6,070 | 6,160 | 6,010 | 6,090 | +30 | +0.5% | 50,200 |
2019/04/19 | 6,080 | 6,130 | 6,000 | 6,060 | +30 | +0.5% | 75,100 |
2019/04/18 | 6,170 | 6,200 | 6,010 | 6,030 | -200 | -3.2% | 132,900 |
2019/04/17 | 6,270 | 6,300 | 6,130 | 6,230 | -110 | -1.7% | 152,400 |
2019/04/16 | 6,490 | 6,680 | 6,300 | 6,340 | +80 | +1.3% | 368,600 |
2019/04/15 | 6,230 | 6,300 | 6,170 | 6,260 | +70 | +1.1% | 70,500 |
2019/04/12 | 6,370 | 6,380 | 6,160 | 6,190 | -150 | -2.4% | 87,100 |
2019/04/11 | 6,350 | 6,390 | 6,260 | 6,340 | ±0 | ±0% | 67,000 |
2019/04/10 | 6,210 | 6,380 | 6,200 | 6,340 | +50 | +0.8% | 104,300 |
2019/04/09 | 6,220 | 6,310 | 6,150 | 6,290 | +100 | +1.6% | 134,000 |
2019/04/08 | 6,130 | 6,300 | 6,070 | 6,190 | +20 | +0.3% | 131,600 |
2019/04/05 | 5,900 | 6,190 | 5,860 | 6,170 | +260 | +4.4% | 163,000 |
2019/04/04 | 5,980 | 5,990 | 5,850 | 5,910 | -130 | -2.2% | 201,000 |
2019/04/03 | 6,280 | 6,300 | 5,970 | 6,040 | -260 | -4.1% | 303,200 |
2019/04/02 | 6,440 | 6,470 | 6,300 | 6,300 | -20 | -0.3% | 164,700 |
2019/04/01 | 6,620 | 6,630 | 6,300 | 6,320 | -200 | -3.1% | 168,900 |
2019/03/29 | 6,700 | 6,740 | 6,360 | 6,520 | +150 | +2.4% | 299,100 |
2019/03/28 | 6,340 | 6,410 | 6,210 | 6,370 | -20 | -0.3% | 101,100 |
2019/03/27 | 6,440 | 6,470 | 6,340 | 6,390 | -10 | -0.2% | 71,200 |
2019/03/26 | 6,310 | 6,430 | 6,270 | 6,400 | +190 | +3.1% | 138,700 |
2019/03/25 | 6,150 | 6,250 | 6,090 | 6,210 | -40 | -0.6% | 114,200 |
2019/03/22 | 6,400 | 6,430 | 6,170 | 6,250 | -250 | -3.8% | 161,700 |
2019/03/20 | 6,350 | 6,520 | 6,320 | 6,500 | +120 | +1.9% | 101,100 |
2019/03/19 | 6,430 | 6,430 | 6,240 | 6,380 | -100 | -1.5% | 78,700 |
2019/03/18 | 6,580 | 6,590 | 6,420 | 6,480 | -140 | -2.1% | 96,200 |
2019/03/15 | 6,520 | 6,620 | 6,470 | 6,620 | +90 | +1.4% | 109,300 |
2019/03/14 | 6,560 | 6,570 | 6,420 | 6,530 | +70 | +1.1% | 95,300 |
2019/03/13 | 6,500 | 6,570 | 6,390 | 6,460 | -50 | -0.8% | 92,100 |
2019/03/12 | 6,540 | 6,630 | 6,480 | 6,510 | +50 | +0.8% | 145,800 |
2019/03/11 | 6,500 | 6,600 | 6,370 | 6,460 | -10 | -0.2% | 87,500 |
2019/03/08 | 6,380 | 6,510 | 6,320 | 6,470 | +10 | +0.2% | 115,700 |
2019/03/07 | 6,440 | 6,570 | 6,350 | 6,460 | -50 | -0.8% | 134,600 |
2019/03/06 | 6,330 | 6,550 | 6,260 | 6,510 | +210 | +3.3% | 154,300 |
2019/03/05 | 6,230 | 6,380 | 6,220 | 6,300 | +10 | +0.2% | 135,200 |
2019/03/04 | 6,300 | 6,300 | 6,200 | 6,290 | +80 | +1.3% | 110,800 |
2019/03/01 | 6,260 | 6,320 | 6,180 | 6,210 | +30 | +0.5% | 133,300 |
1351~
1400
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「JCRファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム